![Frontiers | Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers Frontiers | Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers](https://www.frontiersin.org/files/Articles/811601/fimmu-13-811601-HTML/image_m/fimmu-13-811601-g001.jpg)
Frontiers | Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers
![First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) | Scientific Reports First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-02561-z/MediaObjects/41598_2021_2561_Fig1_HTML.png)
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) | Scientific Reports
![Kaplan–Meier estimates of overall survival according to EGFR status... | Download Scientific Diagram Kaplan–Meier estimates of overall survival according to EGFR status... | Download Scientific Diagram](https://www.researchgate.net/publication/264247700/figure/fig2/AS:202717017448452@1425342911248/Kaplan-Meier-estimates-of-overall-survival-according-to-EGFR-status-EGFR-mutation-and.png)
Kaplan–Meier estimates of overall survival according to EGFR status... | Download Scientific Diagram
![Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR‑TKIs Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR‑TKIs](https://www.spandidos-publications.com/article_images/ol/18/1/ol-18-01-0792-g02.jpg)
Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR‑TKIs
![Kaplan-Meier survival analysis of patients with NSCLC with or without... | Download Scientific Diagram Kaplan-Meier survival analysis of patients with NSCLC with or without... | Download Scientific Diagram](https://www.researchgate.net/publication/255791225/figure/fig1/AS:297817382899712@1448016605090/Kaplan-Meier-survival-analysis-of-patients-with-NSCLC-with-or-without-EGFR-mutations.png)
Kaplan-Meier survival analysis of patients with NSCLC with or without... | Download Scientific Diagram
![The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis | Scientific Reports The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-08449-w/MediaObjects/41598_2022_8449_Fig1_HTML.png)
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis | Scientific Reports
![10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient | European Respiratory Society 10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/1/280/F1.large.jpg)
10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient | European Respiratory Society
![Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health – Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –](https://www.thelancet.com/cms/attachment/7f8ca4e4-a1f7-470f-baca-e75c768839a8/gr1_lrg.jpg)
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
![An exon 21 L858R EGFR mutation is associated with a decreased survival... | Download Scientific Diagram An exon 21 L858R EGFR mutation is associated with a decreased survival... | Download Scientific Diagram](https://www.researchgate.net/publication/333058241/figure/fig3/AS:758145567698948@1557767397979/An-exon-21-L858R-EGFR-mutation-is-associated-with-a-decreased-survival-rate-of-patients.png)
An exon 21 L858R EGFR mutation is associated with a decreased survival... | Download Scientific Diagram
![Cancers | Free Full-Text | A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses Cancers | Free Full-Text | A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses](https://www.mdpi.com/cancers/cancers-13-03641/article_deploy/html/images/cancers-13-03641-g004.png)
Cancers | Free Full-Text | A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
![Critical Review of *EGFR*-Mutated NSCLC What We Do and Do Not Know | Published in healthbook TIMES Oncology Hematology Critical Review of *EGFR*-Mutated NSCLC What We Do and Do Not Know | Published in healthbook TIMES Oncology Hematology](https://s3.amazonaws.com/production.scholastica/public/attachments/8d03762d-8fab-4e85-9bf6-c5571441baf8/large/62035_anonymized_attachment_for_article_24422.png)
Critical Review of *EGFR*-Mutated NSCLC What We Do and Do Not Know | Published in healthbook TIMES Oncology Hematology
![Overall survival in patients with EGFR exon 20 insertions and major... | Download Scientific Diagram Overall survival in patients with EGFR exon 20 insertions and major... | Download Scientific Diagram](https://www.researchgate.net/publication/354724717/figure/fig2/AS:1070708432048147@1632288191406/Overall-survival-in-patients-with-EGFR-exon-20-insertions-and-major-mutations-L858R-and.png)
Overall survival in patients with EGFR exon 20 insertions and major... | Download Scientific Diagram
![Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions | Scientific Reports Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-98275-3/MediaObjects/41598_2021_98275_Fig1_HTML.png)
Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions | Scientific Reports
![Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study - JTO Clinical and Research Reports Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study - JTO Clinical and Research Reports](https://www.jtocrr.org/cms/asset/8f4c3979-0b4b-4c52-b990-627274e985fe/gr3.jpg)
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study - JTO Clinical and Research Reports
![Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis](https://www.mdpi.com/cancers/cancers-14-02519/article_deploy/html/images/cancers-14-02519-g001.png)
Cancers | Free Full-Text | Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis
![Frontiers | Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies Frontiers | Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies](https://www.frontiersin.org/files/Articles/635007/fonc-11-635007-HTML/image_m/fonc-11-635007-g001.jpg)
Frontiers | Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
![The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study | Scientific Reports The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-18889-z/MediaObjects/41598_2022_18889_Fig1_HTML.png)
The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study | Scientific Reports
![Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer | Scientific Reports Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep31636/MediaObjects/41598_2016_Article_BFsrep31636_Fig1_HTML.jpg)
Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer | Scientific Reports
![Overall survival of EGFR-mutated lung adenocarcinoma patients with or... | Download Scientific Diagram Overall survival of EGFR-mutated lung adenocarcinoma patients with or... | Download Scientific Diagram](https://www.researchgate.net/publication/283077881/figure/fig4/AS:613883580526642@1523372659766/Overall-survival-of-EGFR-mutated-lung-adenocarcinoma-patients-with-or-without-the.png)
Overall survival of EGFR-mutated lung adenocarcinoma patients with or... | Download Scientific Diagram
![Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer](https://www.spandidos-publications.com/article_images/mco/11/3/mco-11-03-0301-g00.jpg)
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer
![Effect of gene mutations on the prognosis of lung adenocarcinomas. Blue... | Download Scientific Diagram Effect of gene mutations on the prognosis of lung adenocarcinomas. Blue... | Download Scientific Diagram](https://www.researchgate.net/publication/51161174/figure/fig1/AS:601648313401369@1520455544699/Effect-of-gene-mutations-on-the-prognosis-of-lung-adenocarcinomas-Blue-line-EGFR-group.png)